Detalhe da pesquisa
1.
Medium-term antifungal effects of methylene blue versus flavin mononucleotide in the treatment of moderate toenail onychomycosis.
Mycoses
; 67(1): e13661, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-37840157
2.
Methylene blue vs methyl aminolevulinate photodynamic therapy in the treatment of mild-to-moderate toenail onychomycosis: Short- and medium-term effects.
Dermatol Ther
; 33(6): e14280, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32890444
3.
Successful treatment of Pityriasis Versicolor by photodynamic therapy mediated by methylene blue.
Photodermatol Photoimmunol Photomed
; 36(4): 308-312, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-32191815
4.
Methylene blue vs methyl aminolevulinate photodynamic therapy in combination with oral terbinafine in the treatment of severe dermatophytic toenail onychomycosis: Short- and long-term effects.
Mycoses
; 63(8): 859-868, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32506733
5.
Efficiency of methylene blue-mediated photodynamic therapy vs intense pulsed light in the treatment of onychomycosis in the toenails.
Photodermatol Photoimmunol Photomed
; 35(2): 69-77, 2019 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-30168611
6.
Urea versus fractional Er:YAG laser pretreatment of methylene blue photodynamic therapy in the treatment of moderate toenail onychomycosis: short- and medium-term effects.
Arch Dermatol Res
; 315(4): 787-794, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-36316511
7.
Methyl aminolevulinate photodynamic therapy after partial debulking in the treatment of superficial and nodular basal cell carcinoma: 3-years follow-up.
Photodiagnosis Photodyn Ther
; 33: 102176, 2021 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-33429099
8.
Methyl aminolevulinate-based photodynamic therapy of Bowen´s disease: Observational study of 21 lesions.
Photodiagnosis Photodyn Ther
; 26: 295-299, 2019 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-30986539